Accelerating the integration of China into the global development of innovative anticancer drugs
- Resource Type
- Review Article
- Source
- In
The Lancet Oncology November 2022 23(11):e515-e520 - Subject
Review and Opinion Policy Review - Language
- ISSN
- 1470-2045